Compare WY & CNC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | WY | CNC |
|---|---|---|
| Founded | 1900 | 1984 |
| Country | United States | United States |
| Employees | 9517 | N/A |
| Industry | Real Estate Investment Trusts | Medical Specialities |
| Sector | Real Estate | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 18.4B | 20.0B |
| IPO Year | 1994 | 2001 |
| Metric | WY | CNC |
|---|---|---|
| Price | $25.28 | $43.24 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 7 | 17 |
| Target Price | $29.00 | ★ $41.25 |
| AVG Volume (30 Days) | ★ 6.8M | 6.0M |
| Earning Date | 04-30-2026 | 05-07-2026 |
| Dividend Yield | ★ 3.29% | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ 0.45 | N/A |
| Revenue | $6,905,000,000.00 | ★ $194,777,000,000.00 |
| Revenue This Year | $5.49 | $8.24 |
| Revenue Next Year | $8.69 | $1.34 |
| P/E Ratio | $56.74 | ★ N/A |
| Revenue Growth | N/A | ★ 19.44 |
| 52 Week Low | $21.16 | $25.08 |
| 52 Week High | $31.66 | $66.03 |
| Indicator | WY | CNC |
|---|---|---|
| Relative Strength Index (RSI) | 40.76 | 53.25 |
| Support Level | $26.37 | $38.85 |
| Resistance Level | $27.75 | $43.79 |
| Average True Range (ATR) | 0.70 | 1.57 |
| MACD | -0.23 | 0.26 |
| Stochastic Oscillator | 5.26 | 85.20 |
Weyerhaeuser Co ranks among the world's key forest product companies. Following the 2016 sale of its pulp business to International Paper, Weyerhaeuser operates three business segments: timberlands, wood products, and real estate. Weyerhaeuser is structured as a real estate investment trust and is not required to pay federal income taxes on earnings generated by timber harvest activities. Earnings from its wood products segment are subject to federal income tax. Weyerhaeuser acquired fellow timber REIT Plum Creek in 2016.
Centene is a managed care organization that focuses on government-sponsored healthcare plans, including Medicaid, Medicare, and the individual exchanges. Centene served 22 million medical members as of December 2024, mostly in Medicaid (about 60% of membership), the individual exchanges (about 20%), and Medicare (about 5%). The company also has a military contract and provides Medicare Part D pharmaceutical plans.